Acumen Wealth Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Acumen Wealth Advisors, LLC holds 28 biotech & pharma companies tracked by BioSniper, totaling $31.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
28
Total value held
$31.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 35,663 | $8.7M |
| ABTABBOTT LABORATORIES | 44,981 | $4.6M |
| LLYELI LILLY & Co | 4,366 | $4.0M |
| MRKMerck & Co., Inc. | 27,226 | $3.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,255 | $3.0M |
| DGXQuest Diagnostics Incorporated | 12,504 | $2.5M |
| ELVElevance Health Inc. | 6,935 | $2.0M |
| ABBVAbbVie Inc. | 4,221 | $918K |
| GILDGILEAD SCIENCES, INC. | 6,358 | $886K |
| NVONovo Nordisk A/S | 22,619 | $859K |
| PMPhilip Morris International Inc | 1,173 | $196K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 254 | $113K |
| PFEPFIZER INC | 2,624 | $74K |
| AMGNAMGEN INC | 200 | $70K |
| AZNASTRAZENECA PLC | 137 | $27K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 936 | $23K |
| REGNREGENERON PHARMACEUTICALS, INC. | 24 | $19K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 304 | $17K |
| BMYBRISTOL MYERS SQUIBB CO | 200 | $12K |
| NVSNovartis AG | 63 | $10K |
| KRYSKrystal Biotech, Inc. | 34 | $9K |
| ARGXARGENX SE | 12 | $9K |
| INCYIncyte Corp. | 78 | $7K |
| GEHCGE HealthCare Technologies Inc. | 75 | $5K |
| ONCBeOne Medicines Ltd. | 16 | $5K |
| BAXBaxter International Inc. | 142 | $2K |
| OGNOrganon & Co. | 304 | $2K |
| RDYDR REDDYS LABORATORIES LTD | 105 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.